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ABSTRACT - Among the modifications occurring in the uremic organism, in addition to the consequences of
dialysis, myophathy and peripheral neuropathy are very significant. Children are particularly affected, as their
growth and development are jeopardized. Histochemistry of muscular biopsy was used to study eighteen children
with end-stage renal failure under dialysis during a ten-month period. According to our results, the skeletal
muscular tissue presented the following types of alterations: atrophy, type grouping, lipidosis, glycogen depletion
and mitochondrial proliferation.
KEY WORDS: chronic renal failure, dialysis, muscular biopsy, uremia.
Estudo histoquímico do músculo esquelético em crianças com insuficiência renal crônica em
tratamento dialítico
RESUMO - Dentre as modificações que o organismo urêmico sofre, acrescido das consequências do tratamento
dialítico, miopatia e neuropatia periférica são de real importância. A criança é particularmente afetada, pois seu
crescimento e desenvolvimento estão comprometidos. Foram estudadas dezoito crianças com insuficiência renal
crônica terminal em programa de diálise, num período de dez meses, através da histoquímica da biópsia muscular.
Segundo nossos resultados, o tecido muscular esquelético apresentou alterações tipo atrofia, type grouping,
lipidose, depleção de glicogênio e proliferação mitocondrial.
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The uremic child is severely ill since one of the uremic characteristics is the deep alteration of
the cell energetic metabolism1,2. Nitrogen retention which affects ions transportation and cell
metabolism, that is, biochemical changes (which include damage in the energy use, abnormal
catabolism of carbohydrates, fat and proteins) reflect in the organism as endocrinous disorders,
anemia, delay in growth, malnutrition, osteodystrophy, cardiovascular alterations and neurologic
disorders2,3.
Peripheral neuropathy in patients with chronic renal failure has been known since XIX century.
Kussmaul, in 1864, described adipose degeneration of the myelin sheath in the sciatic nerve of
uremic patients with paresis of the lower limbs4. Histological studies showed destruction of myelin
and axons, predominantly in distal segments of the peripheric nerves5-10.
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Specific myopathy of uremia, non related to polineuropathy, has been reported in histochemical
and ultrastructural studies of the skeletal muscle in adults. Thus, in addition to the preferential
atrophy of type II muscle fibers, secondary to the neural damage, the following characteristics of the
abnormal cytoarchitecture to the coexistent non-neural damage can happen: focal disorganization of
the myofibrillar standard (appearance of moth-eaten fibers of type I fibers), decrease in the amount
of mitochondria, lysosome aggregation in the border of the cell, fragments of myofribils and
disorganization of material in the Z line. However, frank characteristics of myopathy, that is, necrosis
and phagocytosis of fibers are not usually present11.
Lancelotti et al.12 studying the skeletal muscle in undernourished adults observed neurogenic
amyothrophy of varied degrees: presence of atrophic angular type II fibers and nuclear sacs with
varied degrees of intensity lesion in addition to the cases with type grouping, that is, alteration of the
normal mosaic characterized as groupings with only one type of fiber, I or II.
Children’s organism with chronic renal failure (CRF) is still growing and developing, and
dialysis only minimizes the severe defects of uremia while they wait for the transplantation. Although
treated with several types of dialysis procedures, the children still present neuromuscular structural
alterations which have been scarcely appreciated in the literature. The present study has the objective
to show the alterations in which the skeletal muscle of the children, submitted to different dialysis
treatment, suffers when facing a severe condition as that of CRF.
MATERIAL AND METHODS
This study was approved by the committee of ethics (Comissão de Ética Médica, EPM-UNIFESP). Parents
had all information about it, and the children’s inclusion was conditioned to parents’ agreement, formalized by a
Committee document subscription.
Eighteen children with end-stage CRF in a dialysis program, followed-up in the Sector of Pediatric
Neurology of the Department of Pediatrics - UNIFESP-EPM, in a 10 month period were studied. Nine were female
and nine male; ages ranged from 3 to 173 months (mean age 104 months old); diagnosis were listed (Table 1).
The dialysis program varied according to access route, availability and parents’ training: hemodialysis,
intermittent peritoneal dialysis and continuous ambulatorial peritoneal dialysis (CAPD). Time of dialysis varied
from 3 to 34 months.
Biopsy of the deltoid muscle was performed (contralateral to the arteriovenous fistula, when present)
according to the methodology proclaimed by Dubowitz13,14 using the technique of “farabeufs’ dance” of Schmidt15.
After fixation and incision , muscle fragments were submitted to histological staining using methods of
hematoxylin-eosin, modified Gomori trichrome and Sudan red. Histochemical reactions carried out were:
nicotinamide dehydrogenase tetrazolium-reductase (NADH), succinate dehydrogenase (SDH), alpha-
glycerolphosphate-dehydrogenase (alpha-GPD), periodic acid Schiff (PAS), adenosine-triphosphatase (ATPase)
with preincubation at different pHs (pH 4.35, 4.63 and 9.40).
Microscopic analysis aimed to observe the presence or absence of atrophy of muscular fibers, which
resulted of a process in which there is an elongation and a triangular aspect of the muscle fibers, occurring
selectively in type II fibers (anaerobic fibers). This is one of the most frequent abnormalities of the muscle, and
is observed in several neurological diseases and in situations of muscle disuse as extended rest11. Its occurrence
indicates inactivity of the muscle and not the cause. Atrophy degree was expressed in +, ++ or +++ according to
its intensity: slight, moderate or severe, respectively. It may be assessed in the muscle biopsy through hematoxilin-
eosin staining and histochemical reactions with alpha-GPD, ATPase in the already mentioned pHs.
The lipid droplets usually found in small number in the sarcoplasm and with uniform distribution. When
they present a gross aspect and are found in a great number, they characterize a picture that we have called
muscular lipidosis. This was measured in crosses (from + to +++) according to appearance degree. Sudan red
staining was used to measure adipose droplets.
PAS staining was used to detect intrasarcoplasmatic glycogen deposit with the objective to verify the
presence or absence of glycogen depletion.
Oxidative staining (SDH and modified Gomori trichrome) were used to detect abnormalities such as
mitochondria proliferation, which suggests altered cell energetic metabolism. The proliferation was classified as
present or absent and, when present was classified in crosses from + to +++ according to the appearance degree.
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RESULTS
All patients presented atrophy of the muscle cells which selectively impaired type II fibers in
15 patients and in three patients it was non-selective (Table 2). Type grouping occurred in twelve
patients (Fig 1).
All patients presented muscular lipidosis (Fig 1). It was accentuated in four patients, moderate
in four and slight in ten.
Only five patients did not present glycogen depletion.
Eleven patients presented accentuated mitochondria proliferation (Fig 1); it was moderate in
three and accentuated in two. Mitochondria proliferation was not observed only in two patients. The
mitochondria proliferation pattern was diffuse and predominated in the subsarcolemma.
DISCUSSION
In a great or small degree of severity, atrophy of the muscle fibers was present in all biopsies
of our cases, and muscle weakness and exhaustion to physical exercises were observed in these
patients11,16-19. Both patients and uremic animals are hypercatabolics, and in this process there is an
involvement of the skeletal muscle which is a target tissue for catabolism and also for abnormal
Table 1. Sex, age in years and months, dialysis treatment, time of dialysis (td) and nephrology diagnosis.
Case Patient Sex Age1 Age2 Method TD Diagnosis
1 SAR F 13 163 HD 34 Reflux nephropathy
2 EFC M 9 108 HD 17 Reflux nephropathy
3 IAP F 8 99 HD 12 Renal malformation
4 ARS M 8 107 HD 13 Nephronophthisis
5 SB F 3 36 IPD 7 Hemolytic-uremic syndrome
6 EAOS F 5 71 IPD 5 Glomerulonephritis (GN)
7 DCSM M 0 3 IPD 2 Valve of the posterior urethra
8 MRSP F 11 135 IPD 8 Lupus nephritis
9 RRS M 9 117 CAPD 8 Valve of the posterior urethra
10 GSG F 14 173 CAPD 23 Glomerulonephritis (GN)
11 VS F 12 151 CAPD 28 Oxalosis
12 LCRP M 8 100 CAPD 31 Segmental and focal GN
13 FLB M 3 41 CAPD 17 Valve of the posterior urethra
14 MAL M 9 119 CAPD 13 Glomerulonephritis (GN)
15 ES F 13 163 CAPD 11 Renal malformation
16 EDS F 6 75 CAPD 7 Reflux nephropathy
17 MJC M 10 124 CAPD 13 Glomerulonephritis (GN)
18 WFD M 6 80 CAPD 3 Cystinosis
HD, hemodialysis; IPD, intermittent peritoneal dialysis; CAPD, continuous ambulatorial peritoneal dialysis; F, female;
M, male; 1; years; 2, months.
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Fig 1. Left: Type grouping (ATPase, pH 9.40 x 350). Rigth superior: Muscular lipidosis (Sudan red x 500). Rigth
inferior: Mitochondrial proliferation (Gomori trichrome x 350).
metabolism of the hormones (metabolites of vitamin D, PTH, insulin and catecholamines) associated
with the so-called uremic myopathy17,18,20-23.
The atrophy of type II muscle fibers which was predominant in our findings may be present
in neuropathic processes, that is, secondary atrophy to neural damage22. However, the skeletal muscle
can develop alterations independent of the processes which primarily affect the nerve16, called
myogenic myopathy21, mainly affecting type II fibers which is also observed in patients with primary
hyperparathyroidism24,25.
Neurogenic or myogenic atrophy of the muscle fibers which, under microscopic point of
view, occurs in all the muscle groups is considered a severe inconvenience to children, in addition to
the fact of being under growth and development curve. Children, even in dialysis treatment, present
alterations that can be summarized in a clinical evaluation as malnutrition. This is a severe disease
that when observed in uremic children may present muscle trophic alterations due to severe metabolic
changes which probably are independent of the nutrient offer. If our objective was to offer ideal
conditions of growth and development to children, certainly dialysis is not fulfilling this condition.
Differing from the adults who had already reached or had the chance to reach their capacities, the
child, in addition to have the same losses and experienced the same suffering and molestation of the
dialysis treatment, present an incommensurable difficulty to plentifully grow and develop their
potentials. If our efforts could be orientated, they must be in this way, to guarantee a better treatment
for chronic renal failure than that of dialysis.
Type grouping, indicative of amyothrophy process of neurogenic origin, was present in twelve
(66.67%) patients and could be considered as a secondary alteration to peripheral neuropathy11,26,
usually an end-stage complication of renal failure6,20,27.
Skeletal muscle fibers are innervated by neurons from the anterior horn of the spinal cord and
are classified in type I, IIa, IIb and IIc, according to the type of neurons which stimulate them. Thus,
the normal skeletal muscle presents alternations of type I and type II fibers, presenting a “mosaic”
shape when transversally cut and observed by histochemical staining. When neuron is damaged, all
muscle fibers innervated by it, lose their trophic stimulus, atrophying and acquiring an angular
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aspect which characterizes the denervation process. The neighboring neurones which did not suffer
lesions, by budding (sprouting), emit elongations up to atrophied fibers which acquire a new energetic
metabolism, and histochemical reactions similar to the neighboring fibers. Thus, type grouping - a
group of muscle fibers of the same histochemical type - explain the process of reinnervation preceded
by denervation, that is, neurogenic amyothrophy. Type grouping is a pathognomonic alteration of a
neurogenic process characterized by denervertion and renervation. In our sample we had 12 (66.67%)
type grouping, that is, most of our children presented direct or only partial involvement of the
peripheric nerve. This finding adds more evidence to the severe disorder that children under dialysis
procedure are submitted.
It is known that uremia elicits severe alterations in the nervous system, leading to coma
inclusively. Nevertheless, when under dialysis procedures these severe disorders remain controlled
and it is difficult to foresee the hidden effects of the metabolic abnormality on the nervous system.
Our findings allow us to say that these alterations continue occurring although the patient apparently,
in particular the child, does not account for it.
Muscular lipidosis was also present in many degrees of intensity in all biopsy findings, probably
reflecting one more energetic metabolic abnormality in the uremic child, adding, once more, deleteric
Table 2. Main findings of the muscle biopsy.
Case Muscle Type Muscle Muscle glycogen Mitochondria
fibers atrophy grouping lipidosis depletion proliferation
1 ++ Present + Present +
2 +++ Present + Present +
3 + Present ++ Absent ++
4 ++ Present + Present +
5 + Present +++ Present +++
6 ++ Present ++ Absent Absent
7 ++ Absent + Absent Absent
8 +++ Absent + Absent +
9 + Absent + Present +
10 + Present + Present +
11 + Present ++ Present ++
12 +* Absent + Present +
13 +++* Absent ++ Present +
14 +* Absent + Present +
15 ++ Present +++ Present +++
16 ++ Present +++ Present ++
17 ++ Present + Absent +
18 +++ Present +++ Present +
+, slight; ++, moderate; +++, accentuate; *, non-selective atrophy of the fibers.
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elements to the infantile organism. Generally, intrasarcoplasmatic lipid droplets exist in small
quantities and are uniformly distributed. When they present a gross aspect and occur in great number,
they indicate the presence of mithocondriopathies in addition to some muscle atrophies and carnitine
deficit. Lipidic intracellular droplets may be related to muscle deficiency of carnitine once excluded
muscle dystrophies and mithocondriopathies11,19,28. Carnitine deficit elicits the accumulation of lipid
in the cytoplasm (myopathy of lipid storage), which can be evidenced at the muscle histochemistry28-30.
Sixteen cases of mitochondria proliferation (88.89%) in diverse degrees of intensity were
observed. Mitochondria proliferation may suggest a metabolic adaptation because this proliferation
is a response to the adverse conditions that renal chronic organism confronts, clearly depletion of
carnitine which is also responsible by lipidosis11,31-33. In our cases, mitochondria proliferation was
more intense when great lipid accumulation was observed.
Glycogen depletion was observed in thirteen studied children (72.22%). Absence of glycogen
may be associated with the initial phases of denervation34.
Alterations observed in a muscle biopsy of the child are similar to that of the adult11,35 reflecting,
as already mentioned, severe metabolic modifications in the uremic organism. However, consequences
of such conditions in children are most harmful since affect particularly their growth and development.
The choice for dialysis and/or nutrients and vitamin replacement may minimize these alterations
while waiting for renal transplantation, which is the final objective for the patient with chronic renal
failure and specially for the child who might as well find metabolic conditions adequate to needs
and thus being able to thoroughly grow and develop, with a chance to expand his/her capacities.
Few attention has been given to this type of alteration in uremic children and there is a need
to extend this type of research by increasing the number of cases for each specific type of dialysis
used in the treatment with the objective to minimize the effects above characterized.
The results also suggest the need of experimenting some therapeutic effect of the carnitine
that if concomitantly used in dialysis may improve the metabolism, collaborating to reduce nutritional
alterations in uremic children. In brief, the physician must be observing the whole rank of detectable
alterations, aiming a global treatment specially directed to an adequate growth and development of
the child, which is the objective not only of physicians and parents, but of the whole society.
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